Gemcitabine and Nplate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gemcitabine (gemcitabine) and Nplate (romiplostim). Common drug interactions include thrombocytopenia among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Gemcitabine and Nplate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Gemcitabine?

Gemcitabine has active ingredients of gemcitabine. eHealthMe is studying from 31,337 Gemcitabine users. Check the latest studies of Gemcitabine.

What is Nplate?

Nplate has active ingredients of romiplostim. It is often used in idiopathic thrombocytopenic purpura (itp). eHealthMe is studying from 17,850 Nplate users. Check the latest studies of Nplate.

On Aug, 11, 2026

13 people who take Gemcitabine and Nplate together, and have interactions are studied.

Gemcitabine and Nplate drug interactions.

What are the common drug interactions of Gemcitabine and Nplate, by gender? *:

female:

Thrombocytopenia (decrease of platelets in blood)
Drug ineffective
Platelet count decreased
Hospitalisation
Breast cancer
Death
Renal impairment (severely reduced kidney function)

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Drug ineffective
Gingivitis (inflammation of gums)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Thrombocytopenia (decrease of platelets in blood)
Toothache (tooth pain)
Fungal infection
Metastases to adrenals (cancer spreads to adrenal gland of kidney)
Metastases to bone (cancer spreads to bone)

What are the common drug interactions of Gemcitabine and Nplate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Thrombocytopenia (decrease of platelets in blood)
Drug ineffective
Platelet count decreased
Hospitalisation
Breast cancer

40-49:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Drug ineffective
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

50-59:

n/a

60+:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Drug ineffective
Gingivitis (inflammation of gums)
Neutropenia (an abnormally low number of neutrophils)
Renal impairment (severely reduced kidney function)
Thrombocytopenia (decrease of platelets in blood)
Toothache (tooth pain)
Fungal infection
Metastases to adrenals (cancer spreads to adrenal gland of kidney)
Metastases to bone (cancer spreads to bone)

What are the existing conditions these people have? *

Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 10 people, 76.92%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 7.69%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Gemcitabine and Nplate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously